|
FR2850282B1
(fr)
|
2003-01-27 |
2007-04-06 |
Jerome Asius |
Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
|
|
KR20060085246A
(ko)
|
2003-09-18 |
2006-07-26 |
마커사이트, 인코포레이티드 |
경공막 전달
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
WO2006078320A2
(en)
|
2004-08-04 |
2006-07-27 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
|
KR101341359B1
(ko)
*
|
2004-10-01 |
2013-12-13 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
JP5089397B2
(ja)
*
|
2004-11-22 |
2012-12-05 |
サントル ナシオナル ドゥ ラ ルシェルシェ シアンティフィク |
変異ネトリン４、その断片及びこれらの薬剤としての使用
|
|
DK1848431T3
(en)
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
US7592330B2
(en)
*
|
2005-08-08 |
2009-09-22 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
BRPI0620268B8
(pt)
*
|
2005-12-22 |
2021-05-25 |
Oakwood Laboratories LLC |
composição eficaz como sistema de fornecimento para liberação controlada, seu uso, seu método de fabricação, e método para proteger um agente biologicamente ativo
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
US8591531B2
(en)
|
2006-02-08 |
2013-11-26 |
Tyrx, Inc. |
Mesh pouches for implantable medical devices
|
|
MX2008010126A
(es)
*
|
2006-02-08 |
2010-02-22 |
Tyrx Pharma Inc |
Protesis de malla temporalmente rigidizadas.
|
|
KR20140093764A
(ko)
|
2006-02-09 |
2014-07-28 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
WO2007100609A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Albert Einstein College Of Medicine Of Yeshiva University |
Electron transfer through glassy matrices
|
|
ES2563288T3
(es)
*
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
|
US20070265329A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Devang Shah T |
Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
|
|
US20070280902A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Laura Rabinovich-Guilatt |
Method for treating eye disease or conditions affecting the posterior segment of the eye
|
|
EP2359808B1
(en)
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
|
CA2658835A1
(en)
*
|
2006-08-23 |
2008-02-28 |
Novartis Ag |
Use of pkc inhibitors in ocular diseases
|
|
US8821943B2
(en)
*
|
2006-09-12 |
2014-09-02 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for targeted delivery of therapeutic agents
|
|
US20080138350A1
(en)
*
|
2006-10-20 |
2008-06-12 |
Bennett Michael D |
Process for use of fluoroquinolones to reduce or modulate inflammation due to eye disease or ophthalmic surgery
|
|
CA2667890C
(en)
*
|
2006-10-31 |
2015-01-27 |
Surmodics Pharmaceuticals, Inc. |
Spheronized polymer particles
|
|
US9023114B2
(en)
|
2006-11-06 |
2015-05-05 |
Tyrx, Inc. |
Resorbable pouches for implantable medical devices
|
|
MX2009006653A
(es)
|
2006-12-18 |
2009-07-02 |
Takeda Pharmaceutical |
Composicion de liberacion prolongada y metodo para producirla.
|
|
EP2131821B1
(en)
*
|
2007-03-07 |
2018-05-09 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
JP5579057B2
(ja)
*
|
2007-06-01 |
2014-08-27 |
アブラクシス バイオサイエンス， エルエルシー |
再発性癌の処置のための方法および組成物
|
|
US20080317805A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Mckay William F |
Locally administrated low doses of corticosteroids
|
|
US9827210B2
(en)
*
|
2007-06-29 |
2017-11-28 |
Phovitreal Pty Ltd |
Treatment or prophylaxis of a neurological or neuropsychiatric disorders via ocular administration
|
|
KR100882817B1
(ko)
*
|
2007-07-20 |
2009-02-10 |
숙명여자대학교산학협력단 |
보툴리늄 독소를 유효성분으로 포함하는 지방세포 생착증진용 약학적 조성물
|
|
US8124601B2
(en)
*
|
2007-11-21 |
2012-02-28 |
Bristol-Myers Squibb Company |
Compounds for the treatment of Hepatitis C
|
|
WO2009076369A1
(en)
*
|
2007-12-10 |
2009-06-18 |
The Trustees Of The University Of Pennsylvania |
Chitosan-based matrices and uses thereof
|
|
WO2009085952A1
(en)
|
2007-12-20 |
2009-07-09 |
Brookwood Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
|
US20110104253A1
(en)
|
2008-01-18 |
2011-05-05 |
Horst Kief |
Agent for intra-articular injection
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US20090226547A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Gilbard Jeffrey P |
Dietary Supplement For Eye Health
|
|
US9132119B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
US9125917B2
(en)
*
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
CA2730760A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
|
US8697155B2
(en)
*
|
2008-07-22 |
2014-04-15 |
Mayo Foundation For Medical Education And Research |
Treatment of obesity and related disorders
|
|
US20110212127A1
(en)
*
|
2008-09-24 |
2011-09-01 |
Stabilitech Ltd. |
Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
|
|
MX2011003074A
(es)
*
|
2008-09-24 |
2011-04-19 |
Stabilitech Ltd |
Metodo para conservar polipeptidos utilizando un azucar y polietilenimina.
|
|
CN102239149B
(zh)
*
|
2008-10-06 |
2015-05-13 |
约翰·霍普金斯大学 |
喹啉化合物作为血管新生、人类甲硫氨酰氨肽酶、以及sirt1的抑制剂,以及治疗病症的方法
|
|
CN107468648A
(zh)
|
2008-10-09 |
2017-12-15 |
拉姆斯科股份有限公司 |
治疗干眼综合征的组合物和方法
|
|
AT507187B1
(de)
|
2008-10-23 |
2010-03-15 |
Helmut Dr Buchberger |
Inhalator
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
WO2011031476A2
(en)
*
|
2009-08-25 |
2011-03-17 |
Emory University |
Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation
|
|
RU2547990C2
(ru)
|
2009-09-28 |
2015-04-10 |
Интарсия Терапьютикс, Инк. |
Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
|
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
CA2795050C
(en)
|
2010-03-31 |
2018-05-22 |
Stabilitech Ltd. |
Method for preserving alum adjuvants and alum-adjuvanted vaccines
|
|
ES2757591T3
(es)
|
2010-03-31 |
2020-04-29 |
Stabilitech Biopharma Ltd |
Estabilización de partículas virales
|
|
WO2011121301A1
(en)
|
2010-03-31 |
2011-10-06 |
Stabilitech Ltd |
Excipients for stabilising viral particles, polypeptides or biological material
|
|
DE102010013898A1
(de)
*
|
2010-04-01 |
2011-10-06 |
Acino Ag |
Implantatskanüle mit Implantat und Verfahren zum Befestigen von Implantaten in einer Injektionskanüle
|
|
EP3861969A1
(en)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
|
CN103209664A
(zh)
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
CN101972236A
(zh)
*
|
2010-10-13 |
2011-02-16 |
北京诚创康韵医药科技有限公司 |
一种含吡非尼酮的缓释制剂
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
WO2012097258A2
(en)
*
|
2011-01-15 |
2012-07-19 |
The Regents Of The University Of California |
Formulations for the prevention and treatment of wolbachia-related disease
|
|
CA2824970C
(en)
|
2011-02-11 |
2016-05-03 |
Batmark Limited |
Inhaler component
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
HRP20192276T1
(hr)
*
|
2011-06-10 |
2020-05-15 |
Ramscor, Inc. |
Formulacije s produljenim oslobađanjem za dostavu proteina u oko i postupci njihove pripreme
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
|
GB201117233D0
(en)
|
2011-10-05 |
2011-11-16 |
Stabilitech Ltd |
Stabilisation of polypeptides
|
|
US20130190839A1
(en)
*
|
2012-01-20 |
2013-07-25 |
Jane Rapsey |
Drug delivery using a sacrificial host
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
ES3055223T3
(en)
|
2012-05-03 |
2026-02-10 |
Alcon Inc |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
JP6360039B2
(ja)
|
2012-05-03 |
2018-07-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
|
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
UA116217C2
(uk)
|
2012-10-09 |
2018-02-26 |
Санофі |
Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
|
|
US20140105956A1
(en)
*
|
2012-10-11 |
2014-04-17 |
Rupak BANERJEE |
Biodegradable polymer based microimplant for ocular drug delivery
|
|
US9555054B2
(en)
|
2012-11-21 |
2017-01-31 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for reducing oxidative damage
|
|
AU2013366692B2
(en)
|
2012-12-21 |
2017-11-23 |
Sanofi |
Dual GLP1/GIP or trigonal GLP1/GIP/Glucagon agonists
|
|
EP2950782B1
(en)
|
2013-01-31 |
2017-12-27 |
Icon Bioscience, Inc. |
Sustained release formulations for the treatment of intraocular pressure or glaucoma
|
|
EP2956138B1
(en)
|
2013-02-15 |
2022-06-22 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
MX368903B
(es)
|
2013-02-20 |
2019-10-21 |
Kala Pharmaceuticals Inc |
Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas.
|
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
GB2516138C
(en)
*
|
2013-04-09 |
2015-12-09 |
Cresset Biomolecular Discovery Ltd |
The treatment of inflammatory disorders
|
|
KR102245354B1
(ko)
|
2013-05-24 |
2021-04-30 |
아이콘 바이오사이언스, 인크. |
백내장 수술 후 염증에서의 서방출 덱사메타손의 용도
|
|
CA3042642A1
(en)
|
2013-08-12 |
2015-02-19 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
US9458169B2
(en)
|
2013-11-01 |
2016-10-04 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
EP3080152A1
(en)
|
2013-12-13 |
2016-10-19 |
Sanofi |
Non-acylated exendin-4 peptide analogues
|
|
WO2015086728A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
|
|
WO2015086733A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Dual glp-1/glucagon receptor agonists
|
|
EP3080154B1
(en)
|
2013-12-13 |
2018-02-07 |
Sanofi |
Dual glp-1/gip receptor agonists
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
US10172797B2
(en)
|
2013-12-17 |
2019-01-08 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
TW201625670A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑
|
|
TW201625668A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
|
|
TW201625669A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑
|
|
GB201406569D0
(en)
|
2014-04-11 |
2014-05-28 |
Stabilitech Ltd |
Vaccine compositions
|
|
US9956164B2
(en)
|
2014-04-16 |
2018-05-01 |
Veyx-Pharma Gmbh |
Veterinary pharmaceutical composition and use thereof
|
|
US9932381B2
(en)
|
2014-06-18 |
2018-04-03 |
Sanofi |
Exendin-4 derivatives as selective glucagon receptor agonists
|
|
ES2803102T3
(es)
|
2014-07-15 |
2021-01-22 |
Forsight Vision4 Inc |
Dispositivo de administración de implante ocular
|
|
CA2955229C
(en)
|
2014-07-17 |
2020-03-10 |
Pharmaceutical Manufacturing Research Services, Inc. |
Immediate release abuse deterrent liquid fill dosage form
|
|
ES2969374T3
(es)
|
2014-07-30 |
2024-05-17 |
Massachusetts Eye & Ear Infirmary |
Metotrexato para la vitreorretinopatía proliferativa
|
|
RU2017105844A
(ru)
|
2014-08-08 |
2018-09-11 |
Форсайт Вижн4, Инк. |
Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
|
|
CA2958195A1
(en)
*
|
2014-08-15 |
2016-02-18 |
PixarBio Corporation |
Compositions for inhibiting inflammation in a subject with a spinal cord injury and methods of using the same
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
AU2015336065A1
(en)
|
2014-10-20 |
2017-05-04 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended release abuse deterrent liquid fill dosage form
|
|
GB2535427A
(en)
|
2014-11-07 |
2016-08-24 |
Nicoventures Holdings Ltd |
Solution
|
|
CN110478119B
(zh)
|
2014-11-10 |
2022-04-15 |
弗赛特影像4股份有限公司 |
可膨胀药物递送装置和使用方法
|
|
EP3256136A4
(en)
|
2015-02-09 |
2018-11-21 |
University Of Louisville Research Foundation, Inc. |
Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
|
|
US11090296B2
(en)
|
2015-03-18 |
2021-08-17 |
Santen Pharmaceutical Co., Ltd. |
Sustained-release pharmaceutical composition
|
|
RU2730996C2
(ru)
|
2015-06-03 |
2020-08-26 |
Интарсия Терапьютикс, Инк. |
Системы установки и извлечения имплантата
|
|
AR105319A1
(es)
|
2015-06-05 |
2017-09-27 |
Sanofi Sa |
Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
|
|
TW201706291A
(zh)
|
2015-07-10 |
2017-02-16 |
賽諾菲公司 |
作為選擇性肽雙重ｇｌｐ－１／升糖素受體促效劑之新毒蜥外泌肽（ｅｘｅｎｄｉｎ－４）衍生物
|
|
GB2542838B
(en)
|
2015-10-01 |
2022-01-12 |
Nicoventures Trading Ltd |
Aerosol provision system
|
|
CN105496947A
(zh)
*
|
2015-11-19 |
2016-04-20 |
苏州桓晨医疗科技有限公司 |
一种药物缓释制剂
|
|
WO2017087902A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
CN113017981B
(zh)
|
2016-04-05 |
2023-07-25 |
弗赛特影像4股份有限公司 |
药物递送装置
|
|
KR102574993B1
(ko)
|
2016-05-16 |
2023-09-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
WO2017218284A1
(en)
*
|
2016-06-13 |
2017-12-21 |
Massachusetts Eye And Ear Infirmary |
Local orbital therapy for thyroid eye disease
|
|
US10668011B2
(en)
|
2016-06-30 |
2020-06-02 |
Durect Corporation |
Depot formulations
|
|
US10682340B2
(en)
|
2016-06-30 |
2020-06-16 |
Durect Corporation |
Depot formulations
|
|
EP3509423A4
(en)
|
2016-09-08 |
2020-05-13 |
Kala Pharmaceuticals, Inc. |
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF
|
|
AU2017324713B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
US10336767B2
(en)
|
2016-09-08 |
2019-07-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
KR102480965B1
(ko)
|
2016-09-13 |
2022-12-26 |
알레간 인코포레이티드 |
안정화된 비단백질 클로스트리듐 독소 조성물
|
|
JP7286542B2
(ja)
|
2017-01-03 |
2023-06-05 |
インターシア セラピューティクス，インコーポレイティド |
Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
|
|
GB2562241B
(en)
|
2017-05-08 |
2022-04-06 |
Stabilitech Biopharma Ltd |
Vaccine compositions
|
|
CN111655206B
(zh)
|
2017-11-21 |
2022-10-14 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
CN112218659A
(zh)
|
2018-01-02 |
2021-01-12 |
阿玛塔制药股份有限公司 |
用于治疗葡萄球菌感染的治疗性噬菌体组合物
|
|
CN111655171B
(zh)
|
2018-02-08 |
2024-03-08 |
泰尔茂株式会社 |
医疗器具以及使用其的愈合促进器械
|
|
US11065003B2
(en)
|
2018-03-19 |
2021-07-20 |
Terumo Kabushiki Kaisha |
Treatment method for joining biological organs
|
|
CA3097926A1
(en)
|
2018-05-01 |
2019-11-07 |
Chibi, Inc. |
Eye drop formulation and method for sustained delivery of medicament to the retina
|
|
EP4670713A1
(en)
|
2018-05-01 |
2025-12-31 |
Chibi, Inc. |
LIQUID DEPOSIT FOR THE PROLONGED NON-INVASIVE ADMINISTRATION OF AGENTS TO THE IL
|
|
CN112638287A
(zh)
|
2018-09-27 |
2021-04-09 |
泰尔茂株式会社 |
愈合促进器具以及医疗设备
|
|
EP3845149B1
(en)
|
2018-09-27 |
2025-06-11 |
TERUMO Kabushiki Kaisha |
Adhesion promotion device
|
|
EP3932440A4
(en)
|
2019-03-28 |
2022-05-04 |
TERUMO Kabushiki Kaisha |
MEDICAL DEVICE
|
|
EP3932365B1
(en)
|
2019-03-28 |
2025-02-12 |
TERUMO Kabushiki Kaisha |
Adhesion-promoting device
|
|
CN113490458A
(zh)
|
2019-03-28 |
2021-10-08 |
泰尔茂株式会社 |
愈合促进设备
|
|
CN113573747B
(zh)
|
2019-03-28 |
2023-02-24 |
泰尔茂株式会社 |
医疗器具
|
|
EP4028015A4
(en)
|
2019-09-13 |
2023-11-15 |
Aldeyra Therapeutics, Inc. |
Ophthalmic formulations of methotrexate
|
|
US11911499B2
(en)
|
2019-11-07 |
2024-02-27 |
Resurge Therapeutics, Inc. |
System and method for prostate treatment
|
|
CN113262302B
(zh)
*
|
2020-02-17 |
2022-12-09 |
湖州惠中济世生物科技有限公司 |
可注射长效半固体凝胶制剂
|
|
BR112022024461A2
(pt)
*
|
2020-06-01 |
2023-01-31 |
Ads Therapeutics Llc |
Composição oftálmica tópica e método para o tratamento de um distúrbio oftálmico
|
|
EP4178542B1
(en)
*
|
2020-07-07 |
2024-12-04 |
DelSiTech Oy |
Silica hydrogel composite and its use
|
|
FI20215186A1
(en)
*
|
2021-02-19 |
2022-08-20 |
Rebio Tech Oy |
Compositions for ophthalmic treatment
|
|
US11197819B1
(en)
*
|
2021-04-09 |
2021-12-14 |
Drug Delivery Company, Llc |
Extended release bioabsorbable subcutaneous medicinal dosage delivery implant system
|
|
CN115463217B
(zh)
*
|
2021-06-11 |
2024-03-12 |
深圳埃格林医药有限公司 |
己酸羟孕酮在增强肿瘤治疗效果中的应用
|
|
JPWO2023032692A1
(enExample)
|
2021-09-03 |
2023-03-09 |
|
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
US11957654B2
(en)
|
2022-01-29 |
2024-04-16 |
Resurge Therapeutics, Inc. |
Treating benign prostatic hyperplasia
|
|
US11602516B1
(en)
|
2022-01-29 |
2023-03-14 |
Resurge Therapeutics Inc. |
Treating benign prostatic hyperplasia
|
|
US11911385B1
(en)
|
2022-12-14 |
2024-02-27 |
Aldeyra Therapeutics, Inc. |
Methotrexate treatment methods
|
|
WO2025069896A1
(ja)
|
2023-09-29 |
2025-04-03 |
テルモ株式会社 |
生体留置物
|
|
WO2025147589A1
(en)
|
2024-01-05 |
2025-07-10 |
Osanni Bio, Inc. |
Implants, compositions, and methods for treating retinal diseases and disorders
|
|
CN118388331B
(zh)
*
|
2024-05-07 |
2025-05-16 |
山东极地医药科技有限公司 |
一种羟基丙酮的生产工艺
|